ADBE Directional Report
Analysis based on market close March 31, 2026
Outlook
Neutral-to-bearish with a strong gravitational pull toward the $245 max pain pin for the 3/27 expiry, but a multi-week trend of rising max pain suggests underlying bullish drift. Confidence: 8/10. The regime is defined by negative GEX (trending), high IV, and mixed flow with net put premium, favoring directional strategies with a bearish lean near-term.
Conflicts: Rising max pain ladder ($245 → $260+) suggests longer-term bullish positioning, conflicting with near-term put flow.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $-638K
DEX: +11.8M shares
Gamma flip: ~$220 (Approx — based on put OI concentration of 4,731)
NTM gamma: Gamma flip is far below at ~$220, indicating minimal dealer hedging pressure near current spot. With negative GEX, a move ±2% from here will see dealers buying dips and selling rallies, amplifying trends.
IV Analysis
IV vs VIX: IV 49.2% is extremely high (no VIX provided for direct comp, but >40% is elevated for ADBE). This is rich vol, favoring premium selling strategies.
Term structure: Steeply upward sloping near-term (35.5% 2d → 45.6% 79d), then flat. The kink at the 6/18 expiry (45.6%) likely prices in the 6/11 earnings event.
Skew: The ~10 vol-point differential between 2-day (35.5%) and 10-day (38.1%) expiries supports short-dated calendar spreads (sell near, buy farther).
Flow Analysis
Net premium: -$58.9M bearish; P/C vol 1.14 (put-heavy), P/C OI 0.73 (call-heavy).
Directional prints: 1) $235P 4/10: Vol 252 vs OI 2,801 — could be opening put sells (bullish) or buys (bearish). Given net put premium, bearish interpretation is more consistent. 2) $260C 4/17: Vol 100 vs OI 3,687 — likely opening call buys, aligning with longer-term bullish max pain drift.
Unusual: $350P 6/18: Vol 300 vs OI 100 at IV 60.9% — deep OTM protective put purchase or speculative bearish bet; expensive vol suggests hedging.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long stock | Moderate | Buy shares at $243.08. | Immediate downside to $231.63 (1w EM low) in a trending negative GEX regime. |
| Short stock | Moderate-Strong | Sell shares at $243.08, target $235. | Strong put floor at $220 and rising max pain create a powerful bullish magnet over time. |
| Covered call | Strong | Own stock, sell $260C 4/17 (~$2.00 est). | Capped upside if stock rallies toward max pain ladder; stock depreciation. |
| Cash-secured put / put spread | Moderate-Strong | Sell $235/$230 put spread 4/10 (~$1.50 credit est). | Break below $231.63 (1w EM low). |
| Long calls | Moderate-Weak | Buy $250C 5/15 (~$11.00 est) for multi-week bullish drift. | High IV (39.5%) and theta decay; near-term pin/pull to $245. |
| Long puts / bear put spread | Moderate-Strong | Buy $240/$235 put spread 4/10 (~$1.80 debit est). | Pin at $245 holds through 3/27; vol crush on drop. |
| Iron condor | Weak | $235/$230P x $255/$260C 4/10. | GEX negative (trending) and VIX proxy >28 (IV 49.2%) make range-bound strategies risky. |
| Calendar/diagonal | Moderate | Sell $245C 4/2 (IV 35.5%), buy $245C 4/10 (IV 38.1%) for a ~2.6 vol-pt credit. | Directional move away from $245; pin breaks. |
| PMCC / LEAPS diagonal | Moderate-Strong | Buy $210C 1/15/27 (IV 47.2%), sell $260C 4/17 against it. | Capital intensive; near-term stagnation. |
Top Plays
Watchlist Triggers
Tactical Summary
Read the Directional analysis for ADBE for 2026-03-31. This AI-generated report covers regime classification, key price levels, strategy recommendations, and actionable trade ideas drawn from end-of-day options data including gamma exposure, delta exposure, and implied volatility.